Related references
Note: Only part of the references are listed.Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth In Vitro and In Vivo
Yansheng Hao et al.
CLINICAL CANCER RESEARCH (2014)
Inter- and Intra-Patient Heterogeneity of Response and Progression to Targeted Therapy in Metastatic Melanoma
Alexander M. Menzies et al.
PLOS ONE (2014)
The myelodysplastic syndrome as a prototypical epigenetic disease
Jean-Pierre J. Issa
BLOOD (2013)
Environmental factors and unhealthy lifestyle influence oxidative stress in humans-an overview
G. Smilin Bell Aseervatham et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2013)
Genome-wide profiling identifies a DNA methylation signature that associates with TET2 mutations in diffuse large B-cell lymphoma
Fazila Asmar et al.
HAEMATOLOGICA (2013)
Clinical implication of centrosome amplification and expression of centrosomal functional genes in multiple myeloma
Elena Dementyeva et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Tumour heterogeneity and cancer cell plasticity
Corbin E. Meacham et al.
NATURE (2013)
Epidemiology of Myelodysplastic Syndromes
Xiaomei Ma
AMERICAN JOURNAL OF MEDICINE (2012)
Alcohol drinking, tobacco smoking and subtypes of haematological malignancy in the UK Million Women Study
M. E. Kroll et al.
BRITISH JOURNAL OF CANCER (2012)
Intra- and Inter-Tumor Heterogeneity of BRAFV600EMutations in Primary and Metastatic Melanoma
Molly Yancovitz et al.
PLOS ONE (2012)
Myeloperoxidase Expression in Acute Myeloid Leukemia Helps Identifying Patients to Benefit from Transplant
Yundeok Kim et al.
YONSEI MEDICAL JOURNAL (2012)
Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions
Leonidas Benetatos et al.
ANNALS OF HEMATOLOGY (2011)
Aberrant methylation of Polo-like kinase CpG islands in Plk4 heterozygous mice
Alejandra Ward et al.
BMC CANCER (2011)
JAK2V617F-Mediated Phosphorylation of PRMT5 Downregulates Its Methyltransferase Activity and Promotes Myeloproliferation
Fan Liu et al.
CANCER CELL (2011)
Polo-like Kinase Plk2 Is an Epigenetic Determinant of Chemosensitivity and Clinical Outcomes in Ovarian Cancer
Nelofer Syed et al.
CANCER RESEARCH (2011)
Plk5, a Polo Box Domain-Only Protein with Specific Roles in Neuron Differentiation and Glioblastoma Suppression
Guillermo de Carcer et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma
Rita Shaknovich et al.
BLOOD (2010)
DNA Methylation Signatures Identify Biologically Distinct Subtypes in Acute Myeloid Leukemia
Maria E. Figueroa et al.
CANCER CELL (2010)
Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536
Karoline V. Gleixner et al.
CANCER RESEARCH (2010)
DNA Methylation Predicts Survival and Response to Therapy in Patients With Myelodysplastic Syndromes
Lanlan Shen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
A. Tefferi
LEUKEMIA (2010)
Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification
Shinsuke Ito et al.
NATURE (2010)
New insights into the biology and origin of mature aggressive B-cell lymphomas by combined epigenomic, genomic, and transcriptional profiling
Jose I. Martin-Subero et al.
BLOOD (2009)
Polo-like kinase 1 is overexpressed in acute myeloid leukemia and its inhibition preferentially targets the proliferation of leukemic cells
Annelies G. Renner et al.
BLOOD (2009)
Gene expression patterns in heterozygous Plk4 murine embryonic fibroblasts
Alan Morettin et al.
BMC GENOMICS (2009)
Cytogenetic features in myelodysplastic syndromes
Detlef Haase
ANNALS OF HEMATOLOGY (2008)
DNA methylation profiles in diffuse large B-cell lymphoma and their relationship to gene expression status
B. L. Pike et al.
LEUKEMIA (2008)
Bone Marrow Microenvironment and Tumor Progression
Christophe F. Chantrain et al.
CANCER MICROENVIRONMENT (2008)
Analysis of immunohistochemical markers in bone marrow sections to evaluate for myelodysplastic syndromes and acute myeloid leukemias
Cherie H. Dunphy et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2007)
Jak2: normal function and role in hematopoietic disorders
James N. Ihle et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2007)
Tumor suppressor gene methylation in follicular lymphoma: a comprehensive review
John Hayslip et al.
MOLECULAR CANCER (2006)
Promoter hypermethylation of the DNA-repair gene O6-Methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma
Junji Hiraga et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2006)
Epigenetic inactivation implies a tumor suppressor function in hematologic malignancies for Polo-like kinase 2 but not Polo-like kinase 3
Paul Smith et al.
CELL CYCLE (2006)
Clinical implication of centrosome amplification in plasma cell neoplasm
WJ Chng et al.
BLOOD (2006)
Polo-like kinases - A team in control of the division
Barbara C. M. van de Weerdt et al.
CELL CYCLE (2006)
Transcriptional silencing of Polo-like kinase 2 (SNK/PLK2) is a frequent event in B-cell malignancies
N Syed et al.
BLOOD (2006)
Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis
MA Ko et al.
NATURE GENETICS (2005)
A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
C James et al.
NATURE (2005)
Polo-like kinases and oncogenesis
F Eckerdt et al.
ONCOGENE (2005)
Structure and function of Polo-like kinases
DM Lowery et al.
ONCOGENE (2005)
Polo-like kinases (Plks) and cancer
N Takai et al.
ONCOGENE (2005)
Profiling aberrant DNA methylation in hematologic neoplasms: a view from the tip of the iceberg
M Esteller
CLINICAL IMMUNOLOGY (2003)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Late mitotic failure in mice lacking Sak, a polo-like kinase
JW Hudson et al.
CURRENT BIOLOGY (2001)
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
AA Alizadeh et al.
NATURE (2000)
Share Paper
